Related Experiment Video
Updated: Aug 30, 2026

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
Published on: July 16, 2012
The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and
Essam Elsayed1, Richard C Becker
1Department of Medicine, UMass-Memorial Medical Center, Cardiovascular Thrombosis Research Center, University of Massachusetts Medical School, Worcester, MA, USA.
Insights
This review explores how heparin compounds, commonly used anticoagulants, can combat inflammation in atherosclerosis. It examines their anti-inflammatory effects on vascular responses and discusses future research directions for atherothrombosis.
Area of Science:
- Vascular Biology
- Pharmacology
- Inflammation Research
Background:
- Atherosclerotic disease is a chronic inflammatory disorder.
- It involves cellular proliferation and thrombotic activity.
- Links between inflammation, atherogenesis, and thrombogenesis offer pharmaceutical targets.
Purpose of the Study:
- To review the multi-cellular, pleuripotential effects of heparin compounds.
- To examine these effects in normal and disease-altered vascular responses.
- To illustrate avenues for future investigation in atherothrombosis.
Main Methods:
- Review of scientific literature on heparin compounds.
- Analysis of anti-inflammatory properties of the vessel wall.
- Examination of glycosaminoglycans and their relationship with inflammation.
Main Results:
- Heparin exhibits anti-inflammatory effects on cellular responses.
- Molecular weight influences heparin's anti-inflammatory capabilities.
- Oral heparin compounds may offer prolonged cell-based inhibition.
Conclusions:
- Heparin compounds possess significant anti-inflammatory properties relevant to atherothrombosis.
- Further research into heparin's pleuripotential effects is warranted.
- Targeting inflammation with heparin derivatives may be a promising therapeutic strategy.
Abstract:
Atherosclerotic disease is recognized as a chronic inflammatory disorder with intermittent and widely variable phases of cellular proliferation and heightened thrombotic activity. The multi-tiered links between inflammation, atherogenesis and thrombogenesis provide a unique opportunity for research and development of pharmaceuticals which target one or more critical pathobiologic steps (Fig. 1). The purpose of the following review on heparin compounds is to comprehensively examine the multi-cellular, pleuripotential effects of a commonly used anticoagulant drug in the context of normal and disease-altered vascular responses and illustrate possible constructs for avenues of subsequent investigation in the field of atherothrombosis. The overview is divided into five integrated parts; antiinflammatory properties of the normal vessel wall, the relationship between glycosaminoglycans and inflammation, heparin-mediated effects on cellular inflammatory responses, association between molecular weight and antiinflammatory capabilities, and oral heparin compounds for achieving prolonged cell-based inhibition.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Inhibitors of Viral Protein Synthesis
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response I: Vascular and Cellular
Biopharmaceutical Factors Influencing Drug Product Design: Overview

